Medway School of Pharmacy, University of Kent, Kent, UK.
Colloids Surf B Biointerfaces. 2010 Dec 1;81(2):452-60. doi: 10.1016/j.colsurfb.2010.07.040. Epub 2010 Jul 23.
In this article, the influence of agitation in descending and ascending sequences as a systematic method development process for potentially discriminating fed and fasted states and evaluation of its effects on the drug release from swelling gel-forming hydrophilic matrix tablets were investigated. Theophylline extended release (ER) matrices containing hypromellose (hydroxypropyl methylcellulose (HPMC)) were evaluated in media with a pH range of 1.2-7.5, using an automated USP type III, Bio-Dis dissolution apparatus at 5, 10, 15, 20, 25 and 30 dips per minute (dpm). Agitation had a profound effect on the drug release from the HPMC K100LV matrices. Drug release in pH 1.2 changed from about 40% at 5 dpm to about 80% at 30 dpm over a 60 min period alone. The matrices containing HPMC K4M, K15M and K100M however were not significantly affected by the agitation rate. The similarity factor f2 was calculated using drug release at 10 dpm as a reference. The ascending agitations of 5-30 dpm and the descending order of agitation 30-5 dpm were also evaluated. Anomalous transport was the only kinetic of release for the K4M, K15M and K100M tablet matrices. The lower viscous polymer of K100LV had some matrices exhibiting Fickian diffusion as its kinetics of release. The use of systematic change of agitation method may indicate potential fed and fasted effects on drug release from hydrophilic matrices.
本文研究了作为一种系统的方法开发过程,在下降和上升序列中搅拌对区分进食和禁食状态的潜在影响,并评估了其对水凝胶形成亲水性基质片溶出的影响。在 pH 值为 1.2-7.5 的介质中,使用自动 USP Ⅲ型生物分散溶解仪,以每分钟 5、10、15、20、25 和 30 次(dpm)的速度评估含羟丙甲纤维素(羟丙基甲基纤维素(HPMC))的茶碱控释(ER)基质。搅拌对 HPMC K100LV 基质的药物释放有深远的影响。在 pH 1.2 中,药物释放从 5 dpm 时的约 40%增加到 30 dpm 时的约 80%,在 60 分钟内。然而,含有 HPMC K4M、K15M 和 K100M 的基质不受搅拌速率的显著影响。使用 10 dpm 的药物释放作为参考,计算相似因子 f2。还评估了搅拌速度为 5-30 dpm 的上升搅拌和 30-5 dpm 的下降搅拌顺序。异常转运是 K4M、K15M 和 K100M 片剂基质唯一的释放动力学。K100LV 的低粘性聚合物,一些基质显示出其释放动力学为菲克扩散。系统改变搅拌方法的使用可能表明亲水基质药物释放的潜在进食和禁食效应。